oncology
Lung Cancer

How checkpoint inhibitors are changing the outlook for lung cancer

Dr. Horn is an Associate Professor of Medicine and the Clinical Director of the Thoracic Oncology Research Program at Vanderbilt Ingram Cancer Center in Nashville TN. She is also the Assistant Vice Chairman for Faculty Development at Vanderbilt University Medical Center. Her clinical practice focuses on the care of patients with lung cancer.

Read more

Immunotherapy is making its mark in the management of lung cancer – the leading cause of cancer deaths in Australia. Survival is being extended for many patients and new agents have just been added to the PBS for patients who have progressed after chemotherapy. The limbic spoke to Dr Leora Horn, Ingram Associate Professor of ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic